Long-term outcome in 42 pediatric liver transplant patients with alpha 1-antitrypsin deficiency: A single-center experience

Clinical Transplantation

Volumn 25, Issue 5, 2011, Pages 731-736

  Hughes, Michael G ^a,b   Khan, Khalid M ^a,c   Gruessner, Angelika C ^a,c   Sharp, Harvey ^a   Hill, Mark ^a   Jie, Tun ^a   Kandaswamy, Raja ^a   Humar, Abhinav ^a   Payne, William D ^a   Gruessner, Rainer W G ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Biliary atresia; Liver transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN; BILIRUBIN; CYCLOSPORIN A; TACROLIMUS;

AGE DISTRIBUTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BILE DUCT ATRESIA; CHILD; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INFANT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ALPHA 1-ANTITRYPSIN DEFICIENCY; BILIARY ATRESIA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80054103768     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01371.x     Document Type: Article

References (20)

1. Mowat AP. Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr 1992: 151(Suppl 1): S32.
2. Goss JA, Stribling R, Martin P. Adult liver transplantation for metabolic liver disease. Clin Liver Dis 1998: 2: 187.
3. Francavilla R, Castellaneta SP, Hadzic N et al. Prognosis of alpha-1-antitrypsin deficiency-related liver disease in the era of paediatric liver transplantation. J Hepatol 2000: 32: 986.
4. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200, 000 infants. N Engl J Med 1976: 294: 1316.
5. Bowlus CL, Willner I, Zern MA et al. Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol 2005: 3: 390.
6. Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS Liver Transplant Registry. Clin Transplant 2004: 315.
7. Van Furth R, Kramps JA, Van Der Putten AB, Krom RA, Gips CH. Change in alpha 1-antitrypsin phenotype after orthotopic liver transplant. Clin Exp Immunol 1986: 66: 669.
8. Cohen A. Liver transplantation for metabolic disorders. Baillieres Clin Gastroenterol 1989: 3: 767.
9. Arnal FM, Lorenzo MJ, Suarez F et al. Acquired PiZZ alpha-1 antitrypsin deficiency in a liver transplant recipient. Transplantation 2004: 77: 1918.
10. Combs C, Brunt EM, Solomon H et al. Rapid development of hepatic alpha1-antitrypsin globules after liver transplantation for chronic hepatitis C. Gastroenterology 1997: 112: 1372.
11. Elzouki AN, Lindgren S, Nilsson S, Veress B, Eriksson S. Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation. J Hepatol 1997: 26: 1403.
12. Esquivel CO, Vicente E, Van Thiel D et al. Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc 1987: 19: 3798.
13. Filipponi F, Soubrane O, La Brousse F et al. Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation. J Hepatol 1994: 20: 72.
14. Rela M, Muiesan P, Heaton ND et al. Orthotopic liver transplantation for hepatic-based metabolic disorders. Transpl Int 1995: 8: 41.
15. Vennarecci G, Gubson BK, Ismail T et al. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation 1996: 61: 1488.
16. Prachalias AA, Kalife M, Francavilla R et al. Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int 2000: 13: 207.
17. Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003: 9: 527.
18. Utterson EC, Shepherd RW, Sokol RJ et al. Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation. J Pediatr 2005: 147: 180.
19. Fouquet V, Alves A, Branchereau S et al. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005: 11: 152.
20. Diem HV, Evrard V, Vinh HT et al. Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. Transplantation 2003: 75: 1692.